Dehydrocorydaline
Product Specifications
CAS Number
30045-16-0
Target
Autophagy, Parasite, PARP, Caspase, Bcl-2 Family, p38 MAPK
Related Pathways
MAPK, DNA Damage/DNA Repair, Chromatin/Epigenetic, Proteases/Proteasome, Apoptosis, Autophagy, Microbiology/Virology
Purity
0.9984
Bioactivity
1. Dehydrocorydaline (13-Methylpalmatine) exerts anti-metastatic potential via suppression of MMPs and Bcl-2 signaling in NSC-LC cells. 2. Dehydrocorydaline stimulates p38 MAPK activation, which can enhance heterodimerization of MyoD and E proteins, thus resulting in MyoD activation and myoblast differentiation. 3. Dehydrocorydaline shows antiplatelet effects, it inhibits thrombin-induced platelet aggregation in a low dose (IC50= 34.914 ug/mL) . 4. Dehydrocorydaline has anti-inflammatory and antinociceptive effects. 5. Dehydrocorydaline inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.
Smiles
CC1=C2C=3C(=CC(OC)=C(OC)C3)CC[N+]2=CC=4C1=CC=C(OC)C4OC
Molecular Formula
C22H24NO4
Molecular Weight
366.43
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6235487-01 0.1 mL
SORCS2 (VPS10 Domain-containing Receptor SorCS2, KIAA1329) (MaxLight 750)
Sign In for Pricing
View Details MBS6235487-02 5x 0.1 mL
SORCS2 (VPS10 Domain-containing Receptor SorCS2, KIAA1329) (MaxLight 750)
Sign In for Pricing
View Details 
